Biomedical Engineering Reference
In-Depth Information
[97] Chen ZY, He CY, Meuse �, Kay MA. Silencing of episomal transgene expression by
plasmid bacterial DNA elements in vivo . Gene Ther 2004;11:856-64.
[98] �iang KW, Nishikawa M, �iu F, Sun B, Ye Q, Huang �. Restoration of dystrophin
expression in mdx mice by intravascular injection of naked DNA containing full length
dystrophin cDNA. Gene Ther 2004;11:901-8.
[99] Song YK, �iu F, Zhang G, �iu D. Hydrodynamics-based transfection: simple and effi-
cient method for introducing and expressing transgenes in animals by intravenous injec-
tion of DNA. Methods Enzymol 2002;346:92-105.
[100] Suda T, Gao X, Stolz DB, �iu D. Structural impact of hydrodynamic injection on mouse
liver. Gene Ther 2007;14:129-37.
[101] Sebestyen MG, Budker VG, Budker T, Subbotin VM, Zhang G, Monahan SD, et al.
Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte
uptake of various molecules. J Gene Med 2006;8:852-73.
[102] Kobayashi N, Kuramoto T, Yamaoka K, Hashida M, Takakura Y. Hepatic uptake
and gene expression mechanisms following intravenous administration of plasmid
DNA by conventional and hydrodynamics-based procedures. J Pharmacol Exp Ther
2001;297:853-60.
[103] McCaffrey AP, Meuse �, Pham TT, Conklin DS, Hannon GJ, Kay MA. RNA interfer-
ence in adult mice. Nature 2002;418:38-9.
[104] �ewis D�, Hagstrom JE, �oomis AG, Wolff JA, Herweijer H. Efficient delivery of
siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107-8.
[105] Bates MK, Zhang G, Sebestyen MG, Neal ZC, Wolff JA, Herweijer H. Genetic immu-
nization for antibody generation in research animals by intravenous delivery of plasmid
DNA. BioTechniques 2006;40:199-208.
[106] Neal ZC, Bates MK, Albertini MR, Herweijer H. Hydrodynamic limb vein delivery of
a xenogeneic DNA cancer vaccine effectively induces antitumor immunity. Mol Ther
2007;15:422-30.
[107] Cui FD, Asada H, Kishida T, Itokawa Y, Nakaya T, Ueda Y, et al. Intravascular
naked DNA Vaccine encoding glycoprotein B induces protective humoral and cel-
lular immunity against herpes simplex virus type-1 infection in mice. Gene Ther
2003;10:2059-66.
[108] Magin-�achmann C, Kotzamanis G, D'Aiuto �, Cooke H, Huxley C, Wagner E. In vitro
and in vivo delivery of intact BAC DNA: comparison of different methods. J Gene Med
2004;6:195-209.
[109] Chu Q, Joseph M, Przybylska M, Yew NS, Scheule RK. Transient siRNA-mediated
attenuation of liver expression from an alpha-galactosidase a plasmid reduces subse-
quent humoral immune responses to the transgene product in mice. Mol Ther 2005;12:
264-73.
[110] Hodges B�, Taylor KM, Joseph MF, Bourgeois SA, Scheule RK. �ong-term transgene
expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinu-
cleotides. Mol Ther 2004;10:269-78.
[111] Sondergaard M, Dagnaes-Hansen F, Flyvbjerg A, Jensen TG. Normalization of growth
in hypophysectomized mice using hydrodynamic transfer of the human growth hor-
mone gene. Am J Physiol Endocrinol Metab 2003;285:E427-32.
[112] Miao CH, Ye P, Thompson AR, Rawlings DJ, Ochs HD. Immunomodulation of trans-
gene responses following naked DNA transfer of human factor VIII into hemophilia
mice. Blood 2006;108:19-27.
[113] Miao CH. A novel gene expression system: non-viral gene transfer for hemophilia as
model systems. Adv Genet 2005;54:143-77.
Search WWH ::




Custom Search